Maximum quantity allowed is 999
Please select the quantity
CAS RN: 152628-02-9 | Product Number: D5079
1,7'-Dimethyl-2'-propyl-2,5'-bibenzimidazole
×
![]()
×
Purity: >98.0%(HPLC)
Synonyms:
Product Documents:
| Size | Unit Price | Shanghai | Tianjin | Japan* |
|---|---|---|---|---|
| 5G |
¥590.00
|
Contact Us | Contact Us | 2 |
| 25G |
¥2,650.00
|
Contact Us | Contact Us | 5 |
* For order or inquiry, please contact
Our Authorized Distributors.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
* To send your quote request for bulk quantities, please click on the "Request Bulk Quote" button. Please note that we cannot offer bulk quantities for some products.
| Product Number | D5079 |
| Purity / Analysis Method | >98.0%(HPLC) |
| Molecular Formula / Molecular Weight | C__1__9H__2__0N__4 = 304.40 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
| CAS RN | 152628-02-9 |
| Reaxys Registry Number | 6608725 |
| PubChem Substance ID | 468591287 |
| MDL Number | MFCD09029193 |
Specifications
| Appearance | White to Light yellow to Light orange powder to crystaline |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Nonaqueous Titration) | min. 95.0 % |
| NMR | confirm to structure |
Properties (reference)
| Melting Point | 130 °C(dec.) |
| Solubility (soluble in) | Methanol |
GHS
Related Laws:
Transport Information:
| Customs Control Conditions (Q) |
Application
A Key Synthetic Intermediate of Telmisartan
This product has been used as a key synthetic intermediate of telmisartan [T2861] which is an angiotensin II receptor type 1 (AT1) antagonist.
References
- An Efficient and Impurity-Free Process for Telmisartan: An Antihypertensive Drug
- Synthesis and biological activities of novel nonpeptide angiotensin II receptor antagonists based on benzimidazole derivatives bearing a heterocyclic ring
- Design, Synthesis, and Docking Studies of Novel Benzimidazoles for the Treatment of Metabolic Syndrome
- Stability-indicating HPLC method for simultaneous estimation of low level impurities of telmisartan and hydrochlorothiazide in tablet dosage forms
- AQbD-Oriented Development of a New LC Method for Simultaneous Determination of Telmisartan and Its Impurities
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.